[Autophagy] Researchers investigated the therapeutic effects of apoptotic bodies derived from human umbilical cord MSCs on cardiac recovery in a porcine model of myocardial infarction.
[Cellular & Molecular Biology Letters] This study established METTL3 as a critical regulator of the immunosuppressive capacity of MSCs, mediated through inducible nitric oxide synthase expression.
[Journal of Biomaterials Applications] A synergistic bio-electroactive platform was established to specifically induce neuronal differentiation from bone marrow MSCs by coupling spatially oriented, conductive polycaprolactone/reduced graphene oxide nanofibrous scaffolds with exogenous electrical stimulation.
[Bioactive Materials] Investigators developed an innovative universal chimeric antigen receptor (CAR) nanoplatform by engineering MSCs with CAR and integrating them with multifunctional hybrid nanoparticles.
[Journal of Nanobiotechnology] MSCs were delivered into in vivo bone defects with a handheld electrospinning device as an improved cell seeding strategy.
[Stem Cell Research & Therapy] High-dose fresh autologous adipose tissue-MSCs were intravenously administered to 10 female patients with secondary progressive multiple sclerosis in two doses, seven days apart.
[International Journal of Oral Science] Researchers explored a neural crest-like progenitor niche in bone marrow MSCs with high neurogenic and proliferative capacity by single-cell transcriptomics.
[ACS Nano] Scientists developed a hybrid gelled nanovesicle, Hy-gNVs@chol, through chitosan-based protein enrichment and functional membrane replacement, enabling efficient concentration of MSC components to form gel nanoparticles while conferring inflammation-targeting capability.
[Biomaterials Advances] As part of an effort to eliminate synthetic osteogenic compounds, the authors characterized the metabolic adaptations of MSC to chemical-free nanovibration-induced osteodifferentiation.